Biography

John W. Hanna was named Chief Commercial Officer of Veracyte in March 2017. He joined the company in August 2011, and has held senior management positions including Vice President of Marketing and Vice President of Endocrinology. During his tenure, Mr. Hanna has helped define clear patient-centric value propositions for Veracyte’s genomic tests, leading to their broad physician adoption and payer reimbursement. Prior to Veracyte, he held leadership positions with IBM’s Global Healthcare and Life Sciences Division, and Humana, Inc.’s Innovation Center, a division for healthcare consumer research. Mr. Hanna began his career in health policy and advocacy at America’s Health Insurance Plans (AHIP) in Washington, D.C. He currently serves as Chairman of the Reimbursement Workgroup for the Coalition for 21st Century Medicine, which represents the genomic diagnostics industry on policy and regulatory issues. Mr. Hanna holds a Bachelor of Arts degree in Political Science from Hampden-Sydney College in Virginia and an M.B.A. from the University of Miami School of Business.